Dextenza intraocular and Insulin glargine and lixisenatide Subcutaneous
Determining the interaction of Dextenza intraocular and Insulin glargine and lixisenatide Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dexamethasone ophthalmic
Brand name: Dextenza, Dexycu, Ozurdex, Maxidex
Synonyms: Dextenza (intraocular), Dextenza Insert
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin glargine and lixisenatide (Subcutaneous)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dextenza intraocular-Insulin glargine, recombinant Subcutaneous
- Dextenza intraocular-Insulin glulisine
- Dextenza intraocular-Insulin Glulisine (Cartridges and Pens)
- Dextenza intraocular-Insulin Glulisine (Vials)
- Dextenza intraocular-Insulin glulisine Subcutaneous
- Dextenza intraocular-Insulin human inhaled Inhalation
- Insulin glargine and lixisenatide Subcutaneous-Dextran 40
- Insulin glargine and lixisenatide Subcutaneous-Dextran 70 6% in 5% Dextrose high molecular weight
- Insulin glargine and lixisenatide Subcutaneous-Dextran 75
- Insulin glargine and lixisenatide Subcutaneous-Dextran high molecular weight
- Insulin glargine and lixisenatide Subcutaneous-Dextranomer and Hyaluronate Derivatives (Deflux)
- Insulin glargine and lixisenatide Subcutaneous-Dextranomer and Hyaluronate Derivatives (Solesta)